We inferred that the copy number gain in the specific intron region of TPTE2P2 results in the progression of CRC, and the loss of copy number in our decision rules identifies the normal status of MACROD2 and the absence of CRC. This evidence concerns the gene MACROD2 and colorectal carcinoma.